Filing Details

Accession Number:
0001104659-21-154397
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-12-29 21:32:18
Reporting Period:
2021-12-28
Accepted Time:
2021-12-29 21:32:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1641640 Nabriva Therapeutics Plc NBRV () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1378690 R Theodore Schroeder 414 Commerce Dr.
Suite 120
Fort Washington PA 19034
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2021-12-28 100,000 $0.57 325,879 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.5685 to $0.5750, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.